Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Press Releases
Filter articles using the following links
Financial press releases
Events & presentations
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
20 July 2022
GenSight Biologics reports 5 years’ data showing sustained efficacy and safety following one-time treatment with LUMEVOQ®
16 June 2022
GenSight Biologics Announces Participation and Presentation of GS010 Clinical Data at EUNOS 2022
19 May 2022
GenSight Biologics Announces Publication of a Study of the impact of LHON disease on the lives of Patients and Relatives in Journal of Neuro-Ophthalmology
04 May 2022
Annual General Meeting on May 25, 2022 Procedures for obtaining preparatory documents for the General Meeting
29 April 2022
GenSight Biologics Announces the Filing of its 2021 Universal Registration Document
21 April 2022
GenSight Biologics Reports Cash Position and Revenues as of March 31, 2022
14 April 2022
GenSight Biologics Granted Six-Month Extension in LUMEVOQ® European Regulatory Review
08 April 2022
GenSight Biologics Reports Full Year 2021 Consolidated Financial Results
07 April 2022
GenSight Biologics Provides Update on LUMEVOQ® Manufacturing Timeline
11 March 2022
GenSight Biologics Announces its 2022 Financial Calendar
View previous 9 articles
1
2
3
4
5
6
7
8
9
10
11
12
…
40
View next 9 articles
Go back to the page of the page